Precision Optics (POCI) Stock Price, News & Analysis

Company Overview

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

Key Stats

• Today's Range: $5.05 to $5.18
• 50-Day Range: $3.77 to $6.20
• 52-Week Range: $3.47 to $6.90
• Volume: 1,845 shs
• Average Volume: 19,218 shs
• Market Capitalization: $32.45 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Precision Optics Stock Analysis - MarketRank™

Precision Optics scored higher than 18% of companies evaluated by MarketBeat, and ranked 887th out of 956 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Precision Optics.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Precision Optics is -8.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Precision Optics is -8.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Precision Optics has a P/B Ratio of 3.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.12% of the float of Precision Optics has been sold short.

Short Interest Ratio / Days to Cover

Precision Optics has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Precision Optics has recently decreased by 23.81%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Precision Optics does not currently pay a dividend.

Dividend Growth

Precision Optics does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.12% of the float of Precision Optics has been sold short.

Short Interest Ratio / Days to Cover

Precision Optics has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Precision Optics has recently decreased by 23.81%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: -0.10

News Sentiment

Precision Optics has a news sentiment score of -0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Precision Optics this week, compared to 0 articles on an average week.

Search Interest

1 people have searched for POCI on MarketBeat in the last 30 days.

MarketBeat Follows

Only 1 people have added Precision Optics to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Precision Optics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $72,000.00 in company stock.

Percentage Held by Insiders

16.30% of the stock of Precision Optics is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 13.71% of the stock of Precision Optics is held by institutions.

POCI Stock Analysis - Frequently Asked Questions

How have POCI shares performed this year?

Precision Optics' stock was trading at $6.02 at the beginning of 2024. Since then, POCI stock has decreased by 15.1% and is now trading at $5.11.
View the best growth stocks for 2024 here.

How were Precision Optics' earnings last quarter?

Precision Optics Co., Inc. (NASDAQ:POCI) announced its quarterly earnings results on Monday, September, 30th. The company reported ($0.23) EPS for the quarter. The firm had revenue of $4.72 million for the quarter. Precision Optics had a negative trailing twelve-month return on equity of 35.51% and a negative net margin of 20.01%.

Who are Precision Optics' major shareholders?

Precision Optics' top institutional shareholders include Needham Investment Management LLC (6.30%) and Geode Capital Management LLC (0.82%).
View institutional ownership trends.

How do I buy shares of Precision Optics?

Shares of POCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Precision Optics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Precision Optics investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

• Last Earnings: 9/30/2024
• Today: 11/24/2024
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:POCI
• CUSIP: N/A
• CIK: 867840
• Web: www.poci.com
• Phone: (978) 630-1800
• Fax: 978-630-1487
• Employees: 80
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.62)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-2,950,000.00
• Net Margins: -20.01%
• Pretax Margin: -20.00%
• Return on Equity: -35.51%
• Return on Assets: -21.67%

Debt

• Debt-to-Equity Ratio: 0.17
• Current Ratio: 1.41
• Quick Ratio: 0.76

Sales & Book Value

• Annual Sales: $19.10 million
• Price / Sales: 1.70
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.60 per share
• Price / Book: 3.19

Miscellaneous

• Outstanding Shares: 6,350,000
• Free Float: 5,315,000
• Market Cap: $32.45 million
• Optionable: Not Optionable
• Beta: 0.21